Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Colgate Sensitivity, Whitening Pastes Lead “Robust” Q1 Pipeline

This article was originally published in The Tan Sheet

Executive Summary

Colgate-Palmolive is launching Colgate Total Zx Pro-Shield Plus Sensitivity toothpaste and Colgate Optic White Dual Action toothpaste in the U.S. in the first quarter. Net sales in North America in full-year 2012 rose 3.4% to $3.1 billion, the firm reported during an earnings call.

You may also be interested in...



Colgate Total Mouthwash Debut Completes The Brand’s “Regimen”

The mouthwash will join the brand's extensive toothpaste line in a launch supported with a marketing campaign featuring talk-show host Kelly Ripa as spokesperson. The firm’s North American sales grew 5.5% in the first quarter to $764 million, with unit volume increasing 3.5%.

Colgate Total Mouthwash Debut Completes The Brand’s “Regimen”

The mouthwash will join the brand's extensive toothpaste line in a launch supported with a marketing campaign featuring talk-show host Kelly Ripa as spokesperson. The firm’s North American sales grew 5.5% in the first quarter to $764 million, with unit volume increasing 3.5%.

Colgate Bids To Expand U.S. Toothpaste Lineup Through FDA Rulemaking

Colgate seeks regulatory approval for a version of its Colgate Sensitive Multi-Protection toothpaste in a formulation it already markets internationally. The request made in a citizen petition comes after Colgate’s plan to expand its U.S. toothpaste business failed when FDA did not give approval for Sensitive Pro-Relief.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS150923

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel